Piperazine designer drugs of abuse

被引:29
作者
Staack, Roland F. [1 ]
机构
[1] Univ Munich, Inst Forens Med, Dept Forens Toxicol, D-80337 Munich, Germany
关键词
D O I
10.1016/S0140-6736(07)60646-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1411 / 1413
页数:3
相关论文
共 11 条
[1]   Fatal brain oedema after ingestion of ecstasy and benzylpiperazine [J].
Balmelli, C ;
Kupferschmidt, H ;
Rentsch, K ;
Schneemann, M .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2001, 126 (28-29) :809-811
[2]   N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy') [J].
Baumann, MH ;
Clark, RD ;
Budzynski, AG ;
Partilla, JS ;
Blough, BE ;
Rothman, RB .
NEUROPSYCHOPHARMACOLOGY, 2005, 30 (03) :550-560
[3]  
Drug Enforcement Administration (DEA) Department of Justice, 2004, Fed Regist, V69, P12794
[4]  
*EUR MON CTR DRUGS, 2007, EUR EMCDDA JOINT REP
[5]  
Gee Paul, 2005, N Z Med J, V118, pU1784
[6]   Serotonin syndrome after challenge with the 5-HT agonist meta-chlorophenylpiperazine [J].
Klaassen, T ;
Pian, KLH ;
Westenberg, HGM ;
den Boer, JA ;
van Praag, HM .
PSYCHIATRY RESEARCH, 1998, 79 (03) :207-212
[7]   Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping control [J].
Maurer, HH .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2004, 42 (11) :1310-1324
[8]   Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry [J].
Peters, FT ;
Schaefer, S ;
Staack, RF ;
Kraemer, T ;
Maurer, HH .
JOURNAL OF MASS SPECTROMETRY, 2003, 38 (06) :659-676
[9]   Metabolism of designer drugs of abuse [J].
Staack, RF ;
Maurer, HH .
CURRENT DRUG METABOLISM, 2005, 6 (03) :259-274
[10]   A2 (N-benzylpiperazine) a new drug of abuse in Sweden [J].
Wikström, M ;
Holmgren, P ;
Ahlner, J .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2004, 28 (01) :67-70